Viewing Study NCT06863402


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-02-26 @ 5:46 PM
Study NCT ID: NCT06863402
Status: RECRUITING
Last Update Posted: 2025-12-23
First Post: 2025-02-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype
Sponsor: Roswell Park Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Richter Syndrome View
None Diffuse Large B-Cell Lymphoma View
None Chronic Lymphocytic Leukemia View
Keywords: